ArticleJournal of breast cancer2025

Impact of HER2-Low Status on Pathologic Complete Response and Survival Outcome Among Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.

Young Joo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.